Compound ID | 3026
Class: Antimicrobial peptide
| Agent Type: | Natural product; |
| Spectrum of activity: | Antimycobacterial |
| Mechanism of action: | Unknown |
| Target Pathogen: | Active against Mycobacterium phlei and Mycobacterium smegmatis |
| Description: | Natural product from Streptomyces sp.; a lasso peptide; inferior to kanamycin against tuberculosis infection in mice |
| Year first mentioned: | 1958 |
| Highest development stage: | Preclinical (1967) |
| Development status: | Experimental |
| External links: | |
| Guide to Pharmacology: | alboverticillin |
| Citations: |
|